Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP397932.RAKVClpzAkOqVoqp-xp59rQMu14KEp2LMkr3_xuFUaU0A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP397932.RAKVClpzAkOqVoqp-xp59rQMu14KEp2LMkr3_xuFUaU0A130_assertion type Assertion NP397932.RAKVClpzAkOqVoqp-xp59rQMu14KEp2LMkr3_xuFUaU0A130_head.
- NP397932.RAKVClpzAkOqVoqp-xp59rQMu14KEp2LMkr3_xuFUaU0A130_assertion description "[However, the frequency distribution of KLK1 promoter among VUR patients with or without CRI (A, 50.0% and 67.5%; B, 17.9% and 8.3%; H, 14.3% and 18.3%; K, 17.9% and 5.8%, respectively) was statistically different (P = 0.008).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP397932.RAKVClpzAkOqVoqp-xp59rQMu14KEp2LMkr3_xuFUaU0A130_provenance.
- NP397932.RAKVClpzAkOqVoqp-xp59rQMu14KEp2LMkr3_xuFUaU0A130_assertion evidence source_evidence_literature NP397932.RAKVClpzAkOqVoqp-xp59rQMu14KEp2LMkr3_xuFUaU0A130_provenance.
- NP397932.RAKVClpzAkOqVoqp-xp59rQMu14KEp2LMkr3_xuFUaU0A130_assertion SIO_000772 15086490 NP397932.RAKVClpzAkOqVoqp-xp59rQMu14KEp2LMkr3_xuFUaU0A130_provenance.
- NP397932.RAKVClpzAkOqVoqp-xp59rQMu14KEp2LMkr3_xuFUaU0A130_assertion wasDerivedFrom befree-20140225 NP397932.RAKVClpzAkOqVoqp-xp59rQMu14KEp2LMkr3_xuFUaU0A130_provenance.
- NP397932.RAKVClpzAkOqVoqp-xp59rQMu14KEp2LMkr3_xuFUaU0A130_assertion wasGeneratedBy ECO_0000203 NP397932.RAKVClpzAkOqVoqp-xp59rQMu14KEp2LMkr3_xuFUaU0A130_provenance.